Warning: The NCBI web site requires JavaScript to function. more...
Cortactin overexpression results in sustained epidermal growth factor receptor signaling by preventing ligand-induced receptor degradation in human carcinoma cells.
van Rossum AG, Gibcus J, van der Wal J, Schuuring E.
Breast Cancer Res. 2005;7(6):235-7. Epub 2005 Aug 25.
Related citations
Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.
Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA, Daly RJ.
Cancer Res. 2007 Oct 1;67(19):9304-14.
Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P, Lynch DK, Schramek D, Walker F, Daly RJ.
Cancer Res. 2005 Apr 15;65(8):3273-80.
Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification.
Rothschild BL, Shim AH, Ammer AG, Kelley LC, Irby KB, Head JA, Chen L, Varella-Garcia M, Sacks PG, Frederick B, Raben D, Weed SA.
Cancer Res. 2006 Aug 15;66(16):8017-25.
Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma.
Yamada S, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK.
Pathol Oncol Res. 2010 Dec;16(4):523-31. Epub 2010 Jan 13.
The redistribution of cortactin into cell-matrix contact sites in human carcinoma cells with 11q13 amplification is associated with both overexpression and post-translational modification.
van Damme H, Brok H, Schuuring-Scholtes E, Schuuring E.
J Biol Chem. 1997 Mar 14;272(11):7374-80.
Overexpression of cortactin in head and neck squamous cell carcinomas can be uncoupled from augmented EGF receptor expression.
Fantozzi I, Grall D, Cagnol S, Stanchi F, Sudaka A, Brunstein MC, Bozec A, Fischel JL, Milano G, Van Obberghen-Schilling E.
Acta Oncol. 2008;47(8):1502-12.
Amplicon mapping and expression profiling identify the Fas-associated death domain gene as a new driver in the 11q13.3 amplicon in laryngeal/pharyngeal cancer.
Gibcus JH, Menkema L, Mastik MF, Hermsen MA, de Bock GH, van Velthuysen ML, Takes RP, Kok K, Alvarez Marcos CA, van der Laan BF, van den Brekel MW, Langendijk JA, Kluin PM, van der Wal JE, Schuuring E.
Clin Cancer Res. 2007 Nov 1;13(21):6257-66.
Overexpression of cyclin D1 and cortactin is primarily independent of gene amplification in salivary gland adenoid cystic carcinoma.
Greer RO Jr, Said S, Shroyer KR, Marileila VG, Weed SA.
Oral Oncol. 2007 Sep;43(8):735-41. Epub 2006 Nov 17.
Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters.
Lin CK, Su HY, Tsai WC, Sheu LF, Jin JS.
Dis Markers. 2008;25(1):17-26.
Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB, Park S, Lee DY, Hatanpaa KJ, Scoggin SO, Otu H, Libermann TA, Raisanen JM, Ashfaq R, Wong ET, Wu J, Elliott R, Habib AA.
Cancer Res. 2006 Jan 15;66(2):867-74.
Human cortactin as putative cancer antigen.
Lagarkova MA, Boitchenko VE, Mescheryakov AA, Kashkarova UA, Nedospasov SA.
Oncogene. 2000 Oct 26;19(45):5204-7.
Characterization of the EMS1 gene and its product, human Cortactin.
Schuuring E, van Damme H, Schuuring-Scholtes E, Verhoeven E, Michalides R, Geelen E, de Boer C, Brok H, van Buuren V, Kluin P.
Cell Adhes Commun. 1998;6(2-3):185-209.
Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide.
Price KA, Filiz G, Caragounis A, Du T, Laughton KM, Masters CL, Sharples RA, Hill AF, Li QX, Donnelly PS, Barnham KJ, Crouch PJ, White AR.
Int J Biochem Cell Biol. 2008;40(9):1901-17. Epub 2008 Feb 12.
High-resolution mapping identifies a commonly amplified 11q13.3 region containing multiple genes flanked by segmental duplications.
Gibcus JH, Kok K, Menkema L, Hermsen MA, Mastik M, Kluin PM, van der Wal JE, Schuuring E.
Hum Genet. 2007 Apr;121(2):187-201. Epub 2006 Dec 15.
Protein kinase Cdelta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin.
Lladó A, Timpson P, Vilà de Muga S, Moretó J, Pol A, Grewal T, Daly RJ, Enrich C, Tebar F.
Mol Biol Cell. 2008 Jan;19(1):17-29. Epub 2007 Oct 24.
Cortactin promotes migration and platelet-derived growth factor-induced actin reorganization by signaling to Rho-GTPases.
Lai FP, Szczodrak M, Oelkers JM, Ladwein M, Acconcia F, Benesch S, Auinger S, Faix J, Small JV, Polo S, Stradal TE, Rottner K.
Mol Biol Cell. 2009 Jul;20(14):3209-23. Epub 2009 May 20.
Epidermal growth factor receptor (EGFR) signaling in cancer.
Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, Carotenuto A, De Feo G, Caponigro F, Salomon DS.
Gene. 2006 Jan 17;366(1):2-16. Epub 2005 Dec 27. Review.
Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status.
Hofman P, Butori C, Havet K, Hofman V, Selva E, Guevara N, Santini J, Van Obberghen-Schilling E.
Br J Cancer. 2008 Mar 11;98(5):956-64. Epub 2008 Feb 12.
Cortactin expression predicts poor survival in laryngeal carcinoma.
Gibcus JH, Mastik MF, Menkema L, de Bock GH, Kluin PM, Schuuring E, van der Wal JE.
Br J Cancer. 2008 Mar 11;98(5):950-5. Epub 2008 Feb 12.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on